When was Congenica founded?

Congenica was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is Congenica located?

Congenica is headquartered in Cambridge, United Kingdom. It is registered at Bic Wellcome Genome Campus, Hinxton, Cambridge, England, CB10 1DR.

Which legal entities is Congenica associated with?

Congenica is associated with CONGENICA LTD.

How many employees does Congenica have?

As of Jul 31, 2026, the latest employee count at Congenica is 26.

Is Congenica a funded company?

Congenica is a funded company, having raised a total of $81.9M across 11 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 02, 2014.

When was the latest funding round of Congenica?

Congenica's latest funding was a $***** Grant (prize money) round on Jun 17, 2021, with participation from 2 investors. Its primary sector is Genomics. In United Kingdom, the Genomics sector has seen $70.2M in funding in 2026 to date.

What is the annual revenue of Congenica?

Annual revenue of Congenica is between £1M and £10M as on Dec 31, 2024

Where does Congenica rank among its competitors?

Congenica ranks 3rd amongst 541 active competitors, of which 84 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was OutSee, which secured $3.36M in Jan, 2026.

Who are the top competitors of Congenica?

Congenica's top competitors include Benchling, Helix and Sophia Genetics. Among them, OutSee secured the most recent funding round in January, 2026.

Congenica - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of software for clinical genomic interpretation and variant analysis. This platform processes raw sequencing data to identify genetic variants associated with rare diseases, oncology, and infectious conditions. It provides tools for variant ranking and clinical reporting to support diagnostic workflows. The system integrates phenotype data to assist in the assessment of genomic information for medical decision-making.

Website: www.congenica.com/
Social
Phone Number: +44 **********
Registered Address: Bic Wellcome Genome Campus, Hinxton, Cambridge, England, CB10 1DR

Key Metrics

Founded Year

2013

Location

Cambridge, United Kingdom

Stage

Acquired

Total Funding

$81.9M in 11 rounds

Latest Funding Round

Grant (prize money), Jun 17, 2021, $*****

Investors

Tencent & 40 more

Ranked

3^rd among 541 active competitors

Annual Revenue

£1M - £10M as on Dec 31, 2024

Employee Count

26 as on Jul 31, 2026

Similar Companies

Benchling & 695 more

Exit Details

Acquired by SeqOne (Sep 02, 2025)

View Congenica's full profile

Congenica is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CONGENICA LTD CIN: 8273616 , Germany, Active	Oct 29, 2012	£1M - £10M (As on Dec 31, 2024)	79 (As on Dec 31, 2020)

Congenica got acquired by SeqOne on Sep 02, 2025.

Click here to take a look at Congenica's acquisition in detail

Congenica has raised a total funding of $81.9M over 11 rounds. Its first funding round was on May 02, 2014. Its latest funding round was a Grant (prize money) round on Jun 17, 2021 for $*****. 2 investors participated in its latest round. Congenica has 29 institutional investors and 12 angel investors.

Here is the list of recent funding rounds of Congenica:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 17, 2021	8565147	Grant (prize money)	3774399	1561753	9426569	4699903
Nov 09, 2020	3787959	Series C	5804880	8528973	7135643	Cambridge Innovation Capital & 3 more
Apr 30, 2019	5082525	Series B	5681396	1425022	Parkwalk	Digital China Medical

Access funding benchmarks and valuations. Sign up today!

View details of Congenica's funding rounds and investors

The founders of Congenica are Michael Leith Anstey, Richard Durbin, Philip Beales and Tom Weaver.

Here are the details of Congenica's key team members:

Michael Leith Anstey: Board Member of Congenica. They serve on the boards of 2 companies.
Richard Durbin: Co-Founder of Congenica. They serve on the board of 1 company.
Philip Beales: Former Co-Founder of Congenica and founder of 2 other companies, P4 and Axovia Therapeutics.
Tom Weaver: Former Co-Founder of Congenica.
David Atkins: CEO of Congenica.

Congenica's Board of Directors

Congenica's board has 6 active members. Nicholas John Lench, Michael Leith Anstey, Alastair Hugh Lowell Kilgour and Matthew Hurles are part of team and Andy Richards and Shi Wenzhao are independent board members.

Here is the list of Congenica's board of directors:

Name	Type	Representing	Status	Duration
Michael Leith Anstey	Team	-	Current	8y 7m
Matthew Hurles	Team	-	Current	11y 9m
askqoyb	Team	-	Past	3y 8m
dhzkhaz	Team	-	Current	4y 4m
gcteoyx	Team	-	Current	3y 5m
ijtoysc	Team	-	Past	3y 3m
xfkzvtd	Team	-	Past	6y 3m
ofupwrx	Team	-	Past	6y 7m
Andy Richards	Independent board member	-	Current	13y 4m
ody{{kr	Independent board member	-	Current	8y 5m
jousqax	Independent board member	-	Past	4y 6m
unsgcpj	Independent board member	-	Past	1y 1m

View details of Congenica's Founder profiles and Board Members

Congenica's employee count trend

Congenica has 26 employees as of Jul 26. Here is Congenica's employee count trend over the years:

Uncover Congenica's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Congenica include Benchling, Helix and Sophia Genetics. Here is the list of Top 10 competitors of Congenica, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Benchling 2012, San Francisco (United States), Series F	Provider of a cloud-based bioinformatics platform for biotech research	$412M	Altimeter Capital, Benchmark & 29 others	73/100
2nd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 12 others	71/100
3rd	Congenica 2013, Cambridge (United Kingdom), Acquired	Developer of software for clinical genomic interpretation and variant analysis	$81.9M	BioScience Managers, Amadeus & 39 others	62/100
4th	Sophia Genetics 2011, Rolle (Switzerland), Public	Provider of artificial intelligence software for analyzing complex medical data	$249M	Generation Investment Management, Endeavour Vision ... & 24 others	62/100
5th	Latch 2021, San Francisco (United States), Series A	Provider of a web-based platform for genomic bioinformatics	$33M	Lux Capital, Coatue & 7 others	59/100
6th	BostonGene 2015, Waltham (United States), Series B	Developer of cloud-based information and analytics platform to treat cancer	$200M	NEC, Japan Industrial Partners & 1 others	57/100
7th	SeqOne 2017, Montpellier (France), Series A	Provider of bioinformatics tools for the analysis of genome sequencing data	$48.8M	Elaia, Omnes Capital & 7 others	56/100
8th	54gene 2019, Lagos (Nigeria), Deadpooled	Provider of gene biobanking database and services for research purposes	$45M	Better Ventures, Fifty Years & 20 others	54/100
9th	OutSee United Kingdom, Seed	Developer of an artificial intelligence engine for predictive genomics	$5.79M	Ahren, Panacea Venture & 2 others	54/100
10th	Zetta Genomics 2018, Worcester (United Kingdom), Seed	Provider of genomic data analysis software for clinical labs & research organizations	$10.4M	Nina Capital, APEX Ventures & 11 others	54/100